These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2362636)

  • 1. Treatment of a patient with end-stage renal disease, severe iron overload and ascites by weekly phlebotomy combined with recombinant human erythropoietin.
    Nomura S; Osawa G; Karai M
    Nephron; 1990; 55(2):210-3. PubMed ID: 2362636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy.
    McCarthy JT; Johnson WJ; Nixon DE; Jenson BM; Moyer TP
    J Lab Clin Med; 1989 Aug; 114(2):193-9. PubMed ID: 2754306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients.
    Lazarus JM; Hakim RM; Newell J
    Am J Kidney Dis; 1990 Aug; 16(2):101-8. PubMed ID: 2382644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients.
    Agroyannis B; Koutsicos D; Tzanatou-Exarchou H; Varsou-Papadimitriou E; Kapetanaki A; Yatzidis H
    Int J Artif Organs; 1991 Jul; 14(7):403-6. PubMed ID: 1889892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of pancreatic beta-cell function in hemochromatosis: combined treatment with recombinant human erythropoietin and phlebotomy.
    Inoue Y; Nakanishi K; Hiraga T; Okubo M; Murase T; Kosaka K; Miyakoshi S; Mutoh Y; Kobayashi T
    Am J Med Sci; 1997 Dec; 314(6):401-2. PubMed ID: 9413346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment using iron depletion phlebotomy combined with recombinant erythropoietin after allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by secondary hemochromatosis].
    Shinjo K; Takeshita A; Naito K; Ohnishi K; Hirabayashi N; Ohno R
    Rinsho Ketsueki; 2001 Jul; 42(7):571-4. PubMed ID: 11524849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic hemochromatosis: serum ferritin concentrations during therapy by phlebotomy.
    Garry PJ; Saiki JH
    Clin Chem; 1982 Aug; 28(8):1806-8. PubMed ID: 7094303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary haemochromatosis in a haemodialysis patient.
    Cheng L; Tang X; Fu P; Liu F
    Singapore Med J; 2015 Jul; 56(7):e124-6. PubMed ID: 26243982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant erythropoietin and phlebotomy in the treatment of iron overload in uremic patients.
    Chen KS; Leu ML; Huang CC
    Changgeng Yi Xue Za Zhi; 1995 Sep; 18(3):248-53. PubMed ID: 8521335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of plasma erythropoietin concentrations and iron status in hemodialyzed patients not requiring and requiring rHuEpo therapy.
    Majdan M; Ksiazek A; Kozioł M; Spasiewicz D; Swatowski A; Solski J
    Nephron; 1996; 73(3):425-9. PubMed ID: 8832602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of hemosiderosis with regular phlebotomy and recombinant human erythropoietin. Case report and ferrokinetic studies.
    Hotta T; Inoue C; Tsushita K; Miura Y; Saito H
    Acta Haematol; 1991; 86(4):214-6. PubMed ID: 1805491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of iron overload with combination of recombinant human erythropoietin and phlebotomy].
    Nagafuji K; Shibuya T; Yanagida K; Okamura T; Nakamura M; Harada M; Niho Y; Yamano Y
    Rinsho Ketsueki; 1991 Jul; 32(7):791-5. PubMed ID: 1920844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
    Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal hemosiderosis in pediatric patients with nephrogenic ascites.
    Beşbaş N; Söylemezoğlu O; Saatçi U; Bakkaloğlu A; Arslan S; Göğüş S; Topaloğlu R
    Nephron; 1992; 62(3):292-5. PubMed ID: 1436341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
    Taylor JE; Peat N; Porter C; Morgan AG
    Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of iron absorption in iron loaded subjects with end stage renal disease: effects of treatment with recombinant human erythropoietin and reduction of iron stores.
    Hughes RT; Smith T; Hesp R; Hulme B; Dukes DC; Bending MB; Pearson J; Raja KB; Cotes PM; Pippard MJ
    Br J Haematol; 1992 Oct; 82(2):445-54. PubMed ID: 1419827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of intensive phlebotomy therapy in iron overload by serum ferritin assay.
    van Oost BA; van den Beld B; van Asbeck BS; Marx JJ
    Am J Hematol; 1985 Jan; 18(1):7-12. PubMed ID: 3966464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.